I'd like to hear everyone's opinion on the what BOT's course of action will be upon (potentionally) receiving positive results for psoriasis. Will there be another instant insto raise or will they hold tight until other results are released in the hope of gaining a strategic partner?
- Forums
- ASX - By Stock
- Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
I'd like to hear everyone's opinion on the what BOT's course of...
-
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
32.0¢ |
Change
0.005(1.59%) |
Mkt cap ! $707.4M |
Open | High | Low | Value | Volume |
31.5¢ | 32.5¢ | 31.0¢ | $1.169M | 3.655M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 274982 | 31.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 48600 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 423267 | 0.105 |
23 | 1189777 | 0.100 |
1 | 10111 | 0.099 |
1 | 50000 | 0.098 |
1 | 50000 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 555657 | 10 |
0.115 | 560304 | 6 |
0.120 | 829451 | 14 |
0.125 | 1083838 | 12 |
0.130 | 498290 | 12 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
BOT (ASX) Chart |